1. P554 Vedolizumab Associated quality of Life and inflammatory bowel disease control Upon Entering a subcutaneous switching program (VALUE) – Results from a multi-centre UK study. (21st January 2022) Authors: Lim, S; Gros Alcade, B; Lehmann, A; Lindsay, J; Gaya, D; Caulfield, L; Dhar, A; Ritchie, S; Limdi, J; Taylor, J; Raine, T; Balendran, K; Shuttleworth, E; Kwok, J; Cococcia, S; Murray, C; Walker, G; Aldridge, R; George, B; Colbert, R Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P836 Prevalence of anaemia in Italian patients with inflammatory bowel disease: Preliminary results of the observational multi-centre IG-IBD study RIDART 1. (16th January 2018) Authors: Bergamaschi, G; Giuffrida, P; Fries, W; Aronico, N; D'Incà, R; Lenti, M V; Ciacci, C; Cococcia, S; Bossa, F; Ghigliazza, G; Castiglione, F; Principi, M B; Ricci, C; Mazzucco, D; Manetti, N; Scribano, M L; Riegler, G; Bodini, G; Bassotti, G; Monica, F Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S538 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗